Matches in Nanopublications for { ?s ?p "[Therefore, we examined whether the transcriptional deregulation of RB/MDM2 pathway was responsible for DNMT3A overexpression and analyzed the therapeutic potential of MDM2 antagonist for reversing aberrant DNA methylation status in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_assertion description "[Therefore, we examined whether the transcriptional deregulation of RB/MDM2 pathway was responsible for DNMT3A overexpression and analyzed the therapeutic potential of MDM2 antagonist for reversing aberrant DNA methylation status in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_provenance.
- NP539838.RA6wPtXcuwQigGizhzPyWps5dlbKRKu3jFsfg2o3UmwFU130_assertion description "[Therefore, we examined whether the transcriptional deregulation of RB/MDM2 pathway was responsible for DNMT3A overexpression and analyzed the therapeutic potential of MDM2 antagonist for reversing aberrant DNA methylation status in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539838.RA6wPtXcuwQigGizhzPyWps5dlbKRKu3jFsfg2o3UmwFU130_provenance.